Accession Number: | 0001209191-20-026662 |
Date: | 2020-04-30 |
Issuer: | AEGLEA BIOTHERAPEUTICS, INC. (AGLE) |
Original Submission Date: |
QUINN ANTHONY G.
805 LAS CIMAS PARKWAY
SUITE 100
AUSTIN, TX 78746
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-04-30 | P | 165,000 | a | $4.75 | 538,469 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | includes 788 shares acquired by the reporting person on august 15, 2019 and 773 shares acquired by the reporting person on february 15, 2020 pursuant to the issuer's employee stock purchase plan. |